Form 8-K - Current report:
SEC Accession No. 0001213900-24-056205
Filing Date
2024-06-26
Accepted
2024-06-26 17:00:11
Documents
14
Period of Report
2024-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208474-8k_pasithea.htm   iXBRL 8-K 42529
  Complete submission text file 0001213900-24-056205.txt   262789

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ktta-20240626.xsd EX-101.SCH 3810
3 XBRL DEFINITION FILE ktta-20240626_def.xml EX-101.DEF 26681
4 XBRL LABEL FILE ktta-20240626_lab.xml EX-101.LAB 36819
5 XBRL PRESENTATION FILE ktta-20240626_pre.xml EX-101.PRE 25305
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0208474-8k_pasithea_htm.xml XML 5945
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 241074374
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)